- Report
- July 2025
- 50 Pages
Global
From €2328EUR$2,650USD£2,009GBP
Glufosfamide is an oncology drug used to treat certain types of cancer. It is a prodrug of ifosfamide, a chemotherapy drug, and is used to treat advanced or metastatic soft tissue sarcoma. Glufosfamide is administered intravenously and is metabolized in the body to ifosfamide, which is then converted to its active form, 4-hydroxyifosfamide. Glufosfamide is used in combination with other chemotherapy drugs to treat advanced or metastatic soft tissue sarcoma. It is also used in combination with other drugs to treat other types of cancer, such as ovarian cancer and non-small cell lung cancer.
Glufosfamide is approved by the US Food and Drug Administration (FDA) for the treatment of advanced or metastatic soft tissue sarcoma. It is also approved in Europe and other countries for the same indication.
Some companies in the Glufosfamide market include Merck, Pfizer, Novartis, and AstraZeneca. Show Less Read more